Daniel Pink
Daniel Pink publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment and Gastric Cancer Management and Outcomes.
- World rank
- #501,064 of 1,633,909 ranked researchers
- Rank in Germany
- #29,749 of 86,443
- Works
- 35
- Citations
- 77
- Citations per work
- 2.2
What does Daniel Pink research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Oncology28% of their works
- 2Pulmonary and Respiratory Medicine23% of their works
- 3Surgery15% of their works
- 4Gastroenterology12% of their works
- 5Public Health, Environmental and Occupational Health3% of their works
- 6Rheumatology3% of their works
Research topics
Which keywords describe Daniel Pink's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Endoscopic Resection, Osteosarcoma, Soft Tissue Sarcoma, Gastric Cancer and Imatinib Mesylate.
- Chemotherapy-Induced Peripheral Neuropathy
- Patient-Reported Outcomes
- Cancer Survivorship
- Immune Checkpoint Blockade
- KRAS Mutations
- Sunitinib
- Imatinib Mesylate
- Soft Tissue Sarcoma
- Endoscopic Resection
- Clinical Practice Guidelines
- Chemotherapy
- Prognostic Factors
- Osteosarcoma
- Gastric Cancer
- Molecular Characterization
- Cetuximab
- Quality of Life
- PD-1 and PD-L1
- Esophageal Carcinoma
- Preoperative Chemoradiotherapy
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Chemotherapy183 topics
- Clinical Practice Guidelines132 topics
- Prognostic Factors132 topics
- Endoscopic Resection92 topics
- Osteosarcoma71 topic
- Soft Tissue Sarcoma71 topic
- Gastric Cancer61 topic
- Imatinib Mesylate61 topic
- Molecular Characterization61 topic
- Sunitinib61 topic
- Cetuximab51 topic
- KRAS Mutations51 topic
- Quality of Life52 topics
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
- Cancer Survivorship31 topic
- Esophageal Carcinoma31 topic
- Patient-Reported Outcomes31 topic
- Preoperative Chemoradiotherapy31 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Taxanes21 topic
Where does Daniel Pink work?
Daniel Pink's main affiliation in the publication record is Helios Hospital Bad Saarow, Germany.
How many publications and citations does Daniel Pink have?
Science Explorer counts 35 works and 77 citations for Daniel Pink, ranking #501,064 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.